down arrow

Imexpharm Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000IMP0
VND
48,600.00
-400 (-0.82%)

Dec 12

STC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
22,05,119.94
19,94,036.91
16,43,706.51
12,66,596.71
13,69,421.71
14,02,454.49
11,84,817.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
22,05,119.94
19,94,036.91
16,43,706.51
12,66,596.71
13,69,421.71
14,02,454.49
11,84,817.73
Raw Material Cost
13,58,884.99
11,93,903.31
9,56,636.96
7,88,942.41
8,32,522.34
8,84,989.88
7,24,345.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
3,46,113.34
3,41,656.06
3,03,036.49
2,22,039.59
2,42,697.28
2,60,600.14
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3,590.42
6,036.19
3,794.59
6,667.46
6,272.47
3,730.99
1,318.26
Selling and Distribution Expenses
4,31,076.72
4,19,086.65
3,90,569.46
2,43,582.40
2,74,344.64
3,14,422.73
2,91,159.33
Other Expenses
-34,970.38
-34,769.22
-30,683.11
-22,870.70
-24,896.98
-26,433.11
-131.83
Total Expenditure (Excl Depreciation)
17,89,961.71
16,12,989.96
13,47,206.42
10,32,524.82
11,06,866.98
11,99,412.61
10,15,504.74
Operating Profit (PBDIT) excl Other Income
415158.2
381047
296500.1
234071.9
262554.7
203041.9
169313
Other Income
-7,374.88
2,262.17
-1,301.36
11,454.66
-840.92
3,118.21
5,774.71
Operating Profit (PBDIT)
5,13,419.58
4,65,951.40
3,55,584.43
3,05,938.67
3,15,074.78
2,47,628.75
2,05,602.79
Interest
3,590.42
6,036.19
3,794.59
6,667.46
6,272.47
3,730.99
1,318.26
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
8,46,234.95
8,00,133.60
6,87,069.55
4,77,654.29
5,36,899.37
5,17,464.61
4,60,472.33
Depreciation
1,05,636.23
82,642.28
60,385.70
60,412.12
53,360.97
41,468.66
30,515.09
Profit Before Tax
4,04,192.93
3,77,272.93
2,91,404.14
2,38,859.09
2,55,441.34
2,02,429.11
1,73,769.44
Tax
83,330.54
77,716.93
67,863.82
49,764.22
45,744.46
40,042.42
35,086.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,97,535.70
2,54,622.60
1,96,715.48
1,73,368.33
1,79,658.23
1,42,900.28
1,24,683.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,97,535.70
2,54,622.60
1,96,715.48
1,73,368.33
1,79,658.23
1,42,900.28
1,24,683.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,97,535.70
2,54,622.60
1,96,715.48
1,73,368.33
1,79,658.23
1,42,900.28
1,24,683.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
21,83,119.17
20,84,578.94
18,94,446.89
17,94,410.06
17,30,486.17
15,58,889.27
15,04,612.57
Earnings per share (EPS)
1931.94
1653.28
1277.28
1125.69
1200.53
962.96
840.45
Diluted Earnings per share
1931.94
1653.28
1277.28
1125.69
1200.53
962.96
840.45
Operating Profit Margin (Excl OI)
18.83%
19.11%
18.04%
18.48%
19.17%
14.48%
14.29%
Gross Profit Margin
23.12%
23.06%
21.4%
23.63%
22.55%
17.39%
17.24%
PAT Margin
13.49%
12.77%
11.97%
13.69%
13.12%
10.19%
10.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 10.59% vs 21.31% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 16.85% vs 29.44% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 12.32% vs 29.93% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -40.52% vs 59.07% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Imexpharm Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
22,05,119.94
48,84,867.66
-26,79,747.72
-54.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
22,05,119.94
48,84,867.66
-26,79,747.72
-54.86%
Raw Material Cost
13,58,884.99
28,05,590.59
-14,46,705.60
-51.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
3,46,113.34
10,00,468.42
-6,54,355.08
-65.40%
Power Cost
0
0
0.00
Manufacturing Expenses
3,590.42
24,886.18
-21,295.76
-85.57%
Selling and Distribution Expenses
4,31,076.72
12,17,490.52
-7,86,413.80
-64.59%
Other Expenses
-34,970.38
-1,02,535.46
67,565.08
65.89%
Total Expenditure (Excl Depreciation)
17,89,961.71
40,23,081.11
-22,33,119.40
-55.51%
Operating Profit (PBDIT) excl Other Income
4,15,158.23
861,786.55
-4,46,628.32
-51.83%
Other Income
-7,374.88
67,584.20
-74,959.08
-110.91%
Operating Profit (PBDIT)
5,13,419.58
10,99,066.22
-5,85,646.64
-53.29%
Interest
3,590.42
24,886.18
-21,295.76
-85.57%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8,46,234.95
20,79,277.07
-12,33,042.12
-59.30%
Depreciation
1,05,636.23
1,69,695.47
-64,059.24
-37.75%
Profit Before Tax
4,04,192.93
9,04,484.57
-5,00,291.64
-55.31%
Tax
83,330.54
1,25,564.45
-42,233.91
-33.64%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,97,535.70
7,53,552.52
-4,56,016.82
-60.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,97,535.70
7,53,552.52
-4,56,016.82
-60.52%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,97,535.70
7,53,552.52
-4,56,016.82
-60.52%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
21,83,119.17
40,94,755.10
-19,11,635.93
-46.68%
Earnings per share (EPS)
1,931.94
5,762.69
-3,830.75
-66.48%
Diluted Earnings per share
1,931.94
5,762.69
-3,830.75
-66.48%
Operating Profit Margin (Excl OI)
18.83%
17.64%
0.00
1.19%
Gross Profit Margin
23.12%
21.99%
0.00
1.13%
PAT Margin
13.49%
15.43%
0.00
-1.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,20,511.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.59% vs 21.31% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 29,753.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.85% vs 29.44% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52,079.45 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.32% vs 29.93% in Dec 2023

Annual - Interest
Interest 359.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -40.52% vs 59.07% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.83%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."